229 related articles for article (PubMed ID: 9301586)
1. Screening of patients with iron overload to identify hemochromatosis and porphyria cutanea tarda.
O'Reilly FM; Darby C; Fogarty J; Tormey W; Kay EW; Leader M; Murphy GM
Arch Dermatol; 1997 Sep; 133(9):1098-101. PubMed ID: 9301586
[TBL] [Abstract][Full Text] [Related]
2. The frequency of hemochromatosis-associated alleles is increased in British patients with sporadic porphyria cutanea tarda.
Roberts AG; Whatley SD; Nicklin S; Worwood M; Pointon JJ; Stone C; Elder GH
Hepatology; 1997 Jan; 25(1):159-61. PubMed ID: 8985283
[TBL] [Abstract][Full Text] [Related]
3. [Study of the gene of hemochromatosis in first degree relatives of patient with porphyria cutanea tarda].
García-Morillo JS; Carneado de la Fuente J; Stiefel García-Junco P; García-Donas MA; González Escribano MF; Núñez-Roldán A
Med Clin (Barc); 1999 May; 112(18):699-701. PubMed ID: 10374203
[TBL] [Abstract][Full Text] [Related]
4. [Significance and prevalence of the C282Y gene mutation of primary hemochromatosis in the pathogenesis of pophyria cutanea tarda].
Malina L; Zd'árský E; Dandová S; Michalíková H; Cerná M; Cimburová M
Cas Lek Cesk; 2000 Nov; 139(23):728-30. PubMed ID: 11191743
[TBL] [Abstract][Full Text] [Related]
5. Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection.
Martinelli AL; Zago MA; Roselino AM; Filho AB; Villanova MG; Secaf M; Tavella MH; Ramalho LN; Zucoloto S; Franco RF
Am J Gastroenterol; 2000 Dec; 95(12):3516-21. PubMed ID: 11151887
[TBL] [Abstract][Full Text] [Related]
6. Influence of hepatitis C virus (HCV) infection on porphyrin and iron metabolism in porphyria cutanea tarda (PCT) patients.
Dabrowska E; Jabłońska-Kaszewska I; Bielawski KP; Falkiewicz B
Med Sci Monit; 2001 May; 7 Suppl 1():190-6. PubMed ID: 12211718
[TBL] [Abstract][Full Text] [Related]
7. [Hepatitis C, hemochromatosis and porphyria cutanea tarda].
Teubner A; Richter M; Schuppan D; Köstler E; Stölzel U
Dtsch Med Wochenschr; 2006 Mar; 131(13):691-5. PubMed ID: 16555178
[TBL] [Abstract][Full Text] [Related]
8. The association between porphyria cutanea tarda and diabetes mellitus: analysis of a long-term follow-up cohort.
Muñoz-Santos C; Guilabert A; Moreno N; Gimenez M; Darwich E; To-Figueras J; Herrero C
Br J Dermatol; 2011 Sep; 165(3):486-91. PubMed ID: 21564073
[TBL] [Abstract][Full Text] [Related]
9. [Hemochromatosis and porphyria cutanea tarda].
Krivosheev AB; Krivosheev BN
Ter Arkh; 1992; 64(7):81-6. PubMed ID: 1359661
[No Abstract] [Full Text] [Related]
10. Increased serum hepcidin levels in patients with porphyria cutanea tarda.
Darwich E; To-Figueras J; Molina-López RA; Deulofeu R; Olbina G; Westerman M; Sánchez-Tápias JM; Muñoz-Santos C; Herrero C
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e68-74. PubMed ID: 22429447
[TBL] [Abstract][Full Text] [Related]
11. Porphyria cutanea tarda in a Swedish population: risk factors and complications.
Rossmann-Ringdahl I; Olsson R
Acta Derm Venereol; 2005; 85(4):337-41. PubMed ID: 16191856
[TBL] [Abstract][Full Text] [Related]
12. Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda.
Stölzel U; Köstler E; Schuppan D; Richter M; Wollina U; Doss MO; Wittekind C; Tannapfel A
Arch Dermatol; 2003 Mar; 139(3):309-13. PubMed ID: 12622622
[TBL] [Abstract][Full Text] [Related]
13. Genetic hemochromatosis in Italian patients with porphyria cutanea tarda: possible explanation for iron overload.
Fargion S; Fracanzani AL; Romano R; Cappellini MD; Faré M; Mattioli M; Piperno A; Ronchi G; Fiorelli G
J Hepatol; 1996 May; 24(5):564-9. PubMed ID: 8773911
[TBL] [Abstract][Full Text] [Related]
14. Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT).
Lamoril J; Andant C; Gouya L; Malonova E; Grandchamp B; Martásek P; Deybac JC; Puy H
Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):33-41. PubMed ID: 11929045
[TBL] [Abstract][Full Text] [Related]
15. Cascade testing of primary care blood samples with hyperferritinaemia identifies subjects with iron overload and porphyria cutanea tarda.
Baddams EL; Degg T; Barth JH
Ann Clin Biochem; 2014 Jul; 51(Pt 4):499-502. PubMed ID: 24081184
[TBL] [Abstract][Full Text] [Related]
16. Porphyria cutanea tarda--when skin meets liver.
Frank J; Poblete-Gutiérrez P
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):735-45. PubMed ID: 20955974
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the hemochromatosis gene, porphyria cutanea tarda, and iron overload.
Elder GH; Worwood M
Hepatology; 1998 Jan; 27(1):289-91. PubMed ID: 9425949
[No Abstract] [Full Text] [Related]
18. [Determination of serum ferritin in porphyria cutanea tarda. A reliable sign of hepatic siderosis].
Gibertini P; Rocchi E; Cassanelli M; Pietrangelo A; Coppini M; Ventura E
Minerva Med; 1984 Mar; 75(9-10):469-74. PubMed ID: 6709223
[TBL] [Abstract][Full Text] [Related]
19. Iron overload in porphyria cutanea tarda.
Sampietro M; Fiorelli G; Fargion S
Haematologica; 1999 Mar; 84(3):248-53. PubMed ID: 10189391
[TBL] [Abstract][Full Text] [Related]
20. Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda.
Bulaj ZJ; Phillips JD; Ajioka RS; Franklin MR; Griffen LM; Guinee DJ; Edwards CQ; Kushner JP
Blood; 2000 Mar; 95(5):1565-71. PubMed ID: 10688809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
